Diabetes care startup BeatO raised $33 million in funds led by Lighrock India where HealthQuad, Flipkart Ventures and existing investors including Blume Ventures and Leo Capital also participated.
BeatO offers accessible diabetes care with a focus on those who lack access to medical professionals. The company announced that it would use the new funding to expand its operations, hire top leadership, purchase hardware and software, and increase sales of its goods to more people across the nation. With more than 200 million Indians at risk for developing diabetes, the startup predicts that India will soon surpass China to become the world’s diabetes capital.
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Hi, I'm Sreejit Kumar, a journalist with a Master's degree in Journalism. Through my education and professional experience, I have developed a keen eye for detail and a passion for uncovering the truth. As an author for this news website, I am committed to delivering accurate, timely, and engaging stories that inform and entertain our readers.
Diabetes care startup BeatO raised $33 million in funds led by Lighrock India where HealthQuad, Flipkart Ventures and existing investors including Blume Ventures and Leo Capital also participated.
BeatO offers accessible diabetes care with a focus on those who lack access to medical professionals. The company announced that it would use the new funding to expand its operations, hire top leadership, purchase hardware and software, and increase sales of its goods to more people across the nation. With more than 200 million Indians at risk for developing diabetes, the startup predicts that India will soon surpass China to become the world’s diabetes capital.
Disclaimer
We strive to uphold the highest ethical standards in all of our reporting and coverage. We StartupNews.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It’s possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.
Hi, I'm Sreejit Kumar, a journalist with a Master's degree in Journalism. Through my education and professional experience, I have developed a keen eye for detail and a passion for uncovering the truth. As an author for this news website, I am committed to delivering accurate, timely, and engaging stories that inform and entertain our readers.
